COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE
The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction o...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
30.04.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.
L'invention concerne des composés de formule (I) et leurs sels, dans laquelle R1, R2, R3, R4 et X sont tels que définis dans la description. L'invention concerne également leurs procédés de préparation, leurs compositions pharmaceutiques et leurs utilisations en tant que médicament, par exemple pour le traitement d'une maladie ou d'un trouble induit par une réduction ou un déséquilibre du fonctionnement du récepteur de glutamate, par exemple la schizophrénie ou une déficience cognitive. |
---|---|
AbstractList | The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.
L'invention concerne des composés de formule (I) et leurs sels, dans laquelle R1, R2, R3, R4 et X sont tels que définis dans la description. L'invention concerne également leurs procédés de préparation, leurs compositions pharmaceutiques et leurs utilisations en tant que médicament, par exemple pour le traitement d'une maladie ou d'un trouble induit par une réduction ou un déséquilibre du fonctionnement du récepteur de glutamate, par exemple la schizophrénie ou une déficience cognitive. |
Author | NEESOM, JAMES, KENNETH CHAN, WAI, NGOR WARD, SIMON, E HARRISON, STEPHEN HUGHES, OWEN, RHYS THEWLIS, KEVIN, MICHAEL |
Author_xml | – fullname: HARRISON, STEPHEN – fullname: WARD, SIMON, E – fullname: THEWLIS, KEVIN, MICHAEL – fullname: HUGHES, OWEN, RHYS – fullname: NEESOM, JAMES, KENNETH – fullname: CHAN, WAI, NGOR |
BookMark | eNqNyrsKwjAUANAMOvj6hwvOQrQt6BiSW5IhD5pbOpYi10nSQv1_XPwAp7OcvdiUufBOoI4-xT6YDIN12kKKhIGcIgTlk4IONSaKHahgoM-YgSx2GFtwATwap13Ao9i-pvfKp58HcW6RtL3wMo-8LtOTC3_GId6kfMimquu7ulb_rS9Tsi6g |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSÉS QUI POTENTIALISENT LE RÉCEPTEUR AMPA ET LEURS UTILISATIONS EN MÉDECINE |
ExternalDocumentID | WO2009053448A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2009053448A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 11:58:42 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2009053448A13 |
Notes | Application Number: WO2008EP64407 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090430&DB=EPODOC&CC=WO&NR=2009053448A1 |
ParticipantIDs | epo_espacenet_WO2009053448A1 |
PublicationCentury | 2000 |
PublicationDate | 20090430 |
PublicationDateYYYYMMDD | 2009-04-30 |
PublicationDate_xml | – month: 04 year: 2009 text: 20090430 day: 30 |
PublicationDecade | 2000 |
PublicationYear | 2009 |
RelatedCompanies | NEESOM, JAMES, KENNETH GLAXO GROUP LIMITED CHAN, WAI, NGOR WARD, SIMON, E HARRISON, STEPHEN HUGHES, OWEN, RHYS THEWLIS, KEVIN, MICHAEL |
RelatedCompanies_xml | – name: THEWLIS, KEVIN, MICHAEL – name: GLAXO GROUP LIMITED – name: CHAN, WAI, NGOR – name: HARRISON, STEPHEN – name: HUGHES, OWEN, RHYS – name: NEESOM, JAMES, KENNETH – name: WARD, SIMON, E |
Score | 2.7341201 |
Snippet | The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090430&DB=EPODOC&locale=&CC=WO&NR=2009053448A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt2K3Nt32MKRLU1qhSamd29tobQuCdMNV_Pe9xc3taW8hgeMSuI9fLvcLwGNaZkaZ0o7ep12qo5fs6Jlld3WDllavREhiKPriUNj-2HqZ0mkDPje9MIon9EeRI6JFvaO918pfL7aXWK56W7l8yj5wav7sJUNX26DjwYrCSnNHQx5JVzKNMcRtmoj_1qiJYMRBrHSAiXRvZQ_8bbTqS1nsBhXvFA4jlFfVZ9AoqhYcs83fay04CtclbxyurW95DpzJMJJj4b6SiR8wn0Qy4SIJnIQTJ4wcEnPGo0TGxBEuGaOnJInPYy49EgiiiBwDwS_gweMJ83XUZ_a__dlE7ipvXkKzmlfFFRCaWWVumaaRDnLMg4o-ZnvdvIcJmp2baX9wDe19km72L9_CybZy0oZm_fVd3GEArrN7dW6_dmCBSQ |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQGlb8VubffxMKRLU1pdk1Izt7fRri0I0g1X8d_3Vje3p72FBI5L4D5-udwvAI9RFmtZZDbVrtkyVfSSTTU22i1VMzOjkyEk0Ur6Yp-33ZHxMjEnFfjc9MKUPKE_JTkiWtQM7b0o_fVie4lll28rl0_xB07Nnx3Zt5UNOu6tKKwUe9BngbAFVShF3Kbw8G_N1BGMWIiVDjDJ7qzsgb0PVn0pi92g4pzAYYDy8uIUKmlehxrd_L1WhyN_XfLG4dr6lmfAqPADMeL2Gxm7HnVJICTj0rMkI5YfWCRklAVShMTiNhmhpyTSZSETDvE4KYkcPc7O4cFhkroq6jP93_50LHaV1y-gms_z9BKIGRtZYui6FvUSzIPSLmZ7raSDCVo70aNu7woa-yRd71--h5or_eF06PHXGzjeVlEaUC2-vtNbDMZFfFee4S-ylIQ8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+WHICH+POTENTIATE+AMPA+RECEPTOR+AND+USES+THEREOF+IN+MEDICINE&rft.inventor=HARRISON%2C+STEPHEN&rft.inventor=WARD%2C+SIMON%2C+E&rft.inventor=THEWLIS%2C+KEVIN%2C+MICHAEL&rft.inventor=HUGHES%2C+OWEN%2C+RHYS&rft.inventor=NEESOM%2C+JAMES%2C+KENNETH&rft.inventor=CHAN%2C+WAI%2C+NGOR&rft.date=2009-04-30&rft.externalDBID=A1&rft.externalDocID=WO2009053448A1 |